Search

everythinglearnresearchcommunity

for

Search:↓

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

Laser technologies improve medical treatments and outcomes.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Red and near-infrared light-emitting fabric may help improve psoriasis, PMLE, and alopecia areata.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Baricitinib shows promise in treating severe hair loss.

Baricitinib improved hair loss and arthritis in a lupus patient.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Tailored treatments for alopecia areata show promising results, with pulse steroids effective for mild cases and Ritlecitinib, Dupilumab, or methotrexate and prednisone effective for severe cases.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Upadacitinib effectively treated severe hair loss in a child.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

A new lotion with halobetasol and tazarotene successfully treats acne keloidalis nuchae.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

RT1640 treatment reverses gray hair and promotes hair growth in mice.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Targeting Keratin 17 may help overcome cancer therapy resistance.